TSX-V: GENX
About
Team
Contact
Ophthalmics
OTC’s
Investors
AGM Notices
Financials
Research & Development
Products
News
Subscribe
Genix Announces AGM Results
Genix Receives Approval to Extend Warrants from the TSX Venture Exchange
Genix Proposes to Extend Warrants
Genix Pharmaceuticals Corporation Receives Natural Product Number for Rechlor from Health Canada
Menu